NUCKS overexpression in breast cancer

Cancer Cell International

Volumn 9, Issue , 2009, Pages 19-

  Drosos, Yiannis ^a   Kouloukoussa, Mirsini ^b   Østvold, Anne C ^c   Grundt, Kirsten ^c   Goutas, Nikos ^b   Vlachodimitropoulos, Dimitrios ^b   Havaki, Sophia ^b   Kollia, Panagoula ^a   Kittas, Christos ^b   Marinos, Evangelos ^b   Aleporou Marinou, Vassiliki ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; KI 67 ANTIGEN; MESSENGER RNA; NUCLEAR CASEIN KINASE AND CYCLIN DEPENDENT KINASE SUBSTRATE; RNA; UNCLASSIFIED DRUG;

ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; CANCER GRADING; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 70350276180     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/1475-2867-9-19     Document Type: Article

References (35)

1. Walaas SI, Østvold AC, Laland SG. Phosphorylation of P1, a high mobility group-like protein, catalyzed by casein kinase II, protein kinase C, cyclic Amp-dependent protein kinase and calcium/calmodulin-dependent protein kinase II. FEBS Lett 1989, 258:106-108. 10.1016/0014-5793(89)81626-6, 2591527.
2. Maelandsmo GM, Østvold AC, laland SG. Phosphorylation of the high mobility-group like protein P1 by casein kinase II. Eur J Biochem 1989, 184:529-534. 10.1111/j.1432-1033.1989.tb15046.x, 2806236.
3. Meijer L, Østvold AC, Walaas SI, Lund T, Laland SG. High mobility group-like proteins P1, I and Y as substrates of the M-phase specific p34cdc2/cyclin cdc13 kinase. Eur J Biochem 1991, 196:557-567. 10.1111/j.1432-1033.1991.tb15850.x, 2013279.
4. Østvold AC, Norum JH, Mathiesen S, Wanvik B, Sefland I, Grundt K. Molecular cloning of a mammalian nuclear phosphoprotein NUCKS, which serves as a substrate for Cdk1 in vivo. Eur J Biochem 2001, 268:2430-2440. 10.1046/j.1432-1327.2001.02120.x, 11298763.
5. Wiśniewski JR, Zougman A, Krüger S, Ziółkowski P, Pudełko M, Be{ogonek}benek M, Mann M. Constitutive and dynamic phosphorylation and acetylation sites on NUCKS, a hypermodified nuclear protein, studied by quantitative proteomics. Proteins 2008, 73:710-718. 10.1002/prot.22104, 18491381.
6. Grundt K, Haga IV, Aleporou-Marinou V, Drosos Y, Wanvik B, Østvold AC. Characterisation of the NUCKS gene on human chromosome 1q32.1 and the presence of a homologous gene in different species. Biochem Biophys Res Commun 2004, 323:796-801. 10.1016/j.bbrc.2004.08.153, 15381070.
7. Whitfield ML, Sherlock G, Saldanha AJ, Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM, Brown PO, Botstein D. Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors. Mol Biol Cell 2002, 13:1977-2000. 10.1091/mbc.02-02-0030., 117619, 12058064.
8. Thompson HG, Harris JW, Wold BJ, Quake SR, Brody JP. Identification and confirmation of a module of coexpressed genes. Genome Res 2002, 12:1517-1522. 10.1101/gr.418402, 187523, 12368243.
9. Schaner ME, Ross DT, Ciaravino G, Sorlie T, Troyanskaya O, Diehn M, Wang YC, Duran GE, Sikic TL, Caldeira S, Skomedal H, Tu IP, Hernandez-Boussard T, Johnson SW, O'Dwyer PJ, Fero MJ, Kristensen GB, Borresen-Dale AL, Hastie T, Tibshirani R, Rijn M, Teng NN, Longacre TA, Botstein D, Brown PO, Sikic BI. Gene Expression Patterns in Ovarian Carcinomas. Mol Biol Cell 2003, 14:4376-4386. 10.1091/mbc.E03-05-0279, 266758, 12960427.
10. Naylor TL, Greshock J, Wang Y, Colligon T, Yu QC, Clemmer V, Zaks TZ, Weber BL. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridisation. Breast Cancer Res 2005, 7:1186-1198.
11. Sargent LM, Ensell MX, Østvold AC, Baldwin KT, Kashon ML, Lowry DT, Senft JR, Jefferson AM, Johnson RC, Li Z, Tyson FL, Reynolds SH. Chromosomal changes in high- and low-invasive mouse lung adenocarcinoma cell strains derived from early passage mouse lung adenocarcinoma cell strains. Toxicol Appl Pharmacol 2008, 233:81-91. 10.1016/j.taap.2008.01.031, 18367224.
12. Corson TW, Huang A, Tsao MS, Gallie BL. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers. Oncogene 2005, 24:4741-4753. 10.1038/sj.onc.1208641, 15897902.
13. Li Y, Pan J, Li JL, Lee JH, Tunkey C, Saraf K, Garbe JC, Whitley MZ, Jelinsky SA, Stampfer MR, Haney SA. Transcriptional changes associated with breast cancer occur as normal human mammary epithelial cells overcome senescence barriers and become immortalized. Molecular Cancer 2007, 6:7-23. 10.1186/1476-4598-6-7, 1784108, 17233903.
14. Burdall SE, Hanby AM, Lansdown MR, Speirs V. Breast cancer cell lines: friend or foe?. Breast Cancer Res 2003, 5:89-95. 10.1186/bcr577, 154155, 12631387.
15. Tavassoli FA, Devilee P. World Health organization: Pathology and genetics. Tumours of the breast and female genital organs 2003, Lyon, France: IARC Press.
16. Buerger H, Simon R, Schäfer KL, Diallo R, Littmann R, Poremba C, van Diest PJ, Dockhorn-Dworniczak B, Böcker W. Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol 2000, 53:118-121. 10.1136/mp.53.3.118, 1186916, 10897329.
17. Weber-Mangal S, Sinn HP, Popp S, Klaes R, Emig R, Bentz M, Mansmann U, Bastert G, Bartram CR, Jauch A. Breast cancer in young women (>= 35 years): Genomic aberrations detected by comparative genomic hybridization. Int J Cancer 2003, 107:583-592. 10.1002/ijc.11460, 14520696.
18. Loo LW, Grove DI, Williams EM, Neal CL, Cousens LA, Schubert EL, Holcomb IN, Massa HF, Glogovac J, Li CI, Malone KE, Daling JR, Delrow JJ, Trask BJ, Hsu L, Porter PL. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes. Cancer Res 2004, 64:8541-8549. 10.1158/0008-5472.CAN-04-1992, 15574760.
19. Nishizaki T, Chew K, Chu L, Isola J, Kallioniemi A, Weidner N, Waldman FM. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997, 74:513-517. 10.1002/(SICI)1097-0215(19971021)74:5<513::AID-IJC6>3.0.CO;2-6, 9355973.
20. Günther K, Merkelbach-Bruse S, Amo-Takyi BK, Handt S, Schröder W, Tietze L. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. J Pathol 2001, 193:40-47. 10.1002/1096-9896(2000)9999:9999<::AID-PATH745>3.0.CO;2-N, 11169514.
21. Nyante SJ, Devries S, Chen YY, Shelley Hwang E. Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer. Hum Pathol 2004, 35:759-763. 10.1016/j.humpath.2003.11.009, 15188144.
22. Amiel A, Kaufman Z, Goldstein E, Bruchim RB, Kidron D, Gaber E, Fejgin MD. Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast. Cancer Genet Cytogenet 2003, 142:145-148. 10.1016/S0165-4608(02)00833-6, 12699893.
23. Simpson PT, Reis-Filho JS, Gale T, Lakhani SR. Molecular evolution of breast cancer. J Pathol 2005, 205:248-254. 10.1002/path.1691, 15641021.
24. Grundt K, Haga IV, Huitfeldt HS, Østvold AC. Identification and characterization of two putative nuclear localization signals (NLS) in the DNA-binding protein NUCKS. Biochim Biophys Acta-Molecular Cell Research 2007, 1773:1398-1406.
25. Wiese C, Dray E, Groesser T, San Fillipo J, Shi I, Collins DW, Tsai MS, Williams GJ, Rydberg B, Sung P, Schild D. Promotion of homologous recombination and genomic stability by RAD51AP1 via RAD51 recombinase enhancement. Mol Cell 2007, 28:482-490. 10.1016/j.molcel.2007.08.027, 2169287, 17996711.
26. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1138-1139. 10.1126/science.1140321, 17525326.
27. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditulio RA, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434:907-913. 10.1038/nature03485, 15829965.
28. Nguyen DX, Massagué J. Genetic determinants of cancer metastasis. Nat Rev Genet 2007, 8:341-352. 10.1038/nrg2101, 17440531.
29. Pusztai L. Current Status of Prognostic Profiling in Breast Cancer. Oncologist 2008, 13:350-360. 10.1634/theoncologist.2007-0216, 18448548.
30. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF. The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells. N Engl J Med 2007, 356:217-226. 10.1056/NEJMoa063994, 17229949.
31. Holland R, Peterse JL, Millis RR, Eusebi V, Faverly D, Vijver MJ, Zafrani B. Ductal carcinoma in situ: a proposal for a new classification. Semin Diagn Path 1994, 11:167-180.
32. Robbins P, Pinder S, de Klerk N, Dawkins H, Harvey J, Sterrett G, Ellis I, Elston C. Histological grading of breast carcinomas: a study of interobserved agreement. Hum Pathol 1995, 26:873-879. 10.1016/0046-8177(95)90010-1, 7635449.
33. Havaki S, Kouloukoussa M, Amawi K, Drosos Y, Arvanitis LD, Goutas N, Vlachodimitropoulos D, Vassilaros SD, Katsantoni EZ, Voloudakis-Baltatzis I, Aleporou-Marinou V, Kittas C, Marinos E. Altered expression pattern of integrin alphavbeta3 correlates with actin cytoskeleton in primary cultures of human breast cancer. Cancer Cell International 2007, 7:16-28. 10.1186/1475-2867-7-16, 2116995, 17910753.
34. Kouloukoussa M, Panagopoulou E, Marinos E. The in vitro effect of the tumor promoter 12-0-tetradecanoylphorbol-13-acetate on Sertoli cell morphology. Cancer Detect Prev 1999, 23:280-289. 10.1046/j.1525-1500.1999.99030.x, 10403899.
35. Stavroyianni N, Belessi C, Stamatopoulos K, Kosmas C, Paterakis G, Abazis D, Pangalos C, Yataganas X. Expression of recombination activating genes-1 and-2 immunoglobulin heavy chain gene rearrangements in acute myeloid leukemia: evaluation of biological and clinical significance in a series of 76 uniformly treated patients and review of the literature. Haematologica 2003, 88:268-274.